Haematologica, Volume 107, Issue 11 by Haematologica - Issuu
Haematologica, Volume 106, Issue 1 by Haematologica - Issuu
Haematologica, Volume 102, issue 12 by Haematologica - Issuu
Haematologica, Volume 106, Issue 5 by Haematologica - Issuu
Haematologica, Volume 105, Issue 3 by Haematologica - Issuu
Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment | Blood Cancer Journal
Haematologica, Volume 106, Issue 2 by Haematologica - Issuu
Haematologica, Volume 107, Issue 7 by Haematologica - Issuu
Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged
Untitled
PDF) Use of the HLA-B leader to optimize cord-blood transplantation
Haematologica, Volume 102, issue 10 by Haematologica - Issuu
Haematologica, Volume 106, Issue 11 by Haematologica - Issuu
Ferrata Storti Foundation
Frontiers | Effects of ibrutinib on T-cell immunity in patients with chronic lymphocytic leukemia
Untitled
Vol. 102 No. 4 (2017): April, 2017 | Haematologica
Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells: Molecular Therapy - Methods & Clinical Development
Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease | Haematologica
Prediction and validation of hematopoietic stem and progenitor cell off-target editing in transplanted rhesus macaques: Molecular Therapy
PDF) The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia
